MDXH
Price:
$1.88
Market Cap:
$93.05M
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2021-11-04
Stock Exchange
NASDAQ
Ticker
MDXH
According to MDxHealth SA’s latest financial reports and current stock price. The company's current PE Ratio is -1.23. This represents a change of -39.78% compared to the average of -2.04 of the last 4 quarters.
The mean historical PE Ratio of MDxHealth SA over the last ten years is -3.06. The current -1.23 PE Ratio has changed 3.91% with respect to the historical average. Over the past ten years (40 quarters), MDXH's PE Ratio was at its highest in in the March 2017 quarter at 60.00. The PE Ratio was at its lowest in in the March 2021 quarter at -5.00.
Average
-3.06
Median
-3.03
Minimum
-4.87
Maximum
-1.74
Discovering the peaks and valleys of MDxHealth SA PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 90.96%
Maximum Annual PE Ratio = -1.74
Minimum Annual Increase = -56.29%
Minimum Annual PE Ratio = -4.87
Year | PE Ratio | Change |
---|---|---|
2023 | -2.37 | 13.35% |
2022 | -2.09 | -44.42% |
2021 | -3.76 | 12.99% |
2020 | -3.33 | 90.96% |
2019 | -1.74 | -18.22% |
2018 | -2.13 | -56.29% |
2017 | -4.87 | 16.14% |
2016 | -4.20 | 22.64% |
2015 | -3.42 | 25.18% |
2014 | -2.73 | 22.68% |
The current PE Ratio of MDxHealth SA (MDXH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.74
5-year avg
-2.66
10-year avg
-3.06
MDxHealth SA’s PE Ratio is greater than Inozyme Pharma, Inc. (-1.84), greater than Day One Biopharmaceuticals, Inc. (-15.73), greater than Acumen Pharmaceuticals, Inc. (-1.74), less than Eledon Pharmaceuticals, Inc. (17.15), less than Elevation Oncology, Inc. (-0.85),
Company | PE Ratio | Market cap |
---|---|---|
-1.84 | $180.51M | |
-15.73 | $1.38B | |
-1.74 | $142.39M | |
17.15 | $239.55M | |
-0.85 | $35.67M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MDxHealth SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MDxHealth SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is MDxHealth SA's PE Ratio?
How is the PE Ratio calculated for MDxHealth SA (MDXH)?
What is the highest PE Ratio for MDxHealth SA (MDXH)?
What is the 3-year average PE Ratio for MDxHealth SA (MDXH)?
What is the 5-year average PE Ratio for MDxHealth SA (MDXH)?
How does the current PE Ratio for MDxHealth SA (MDXH) compare to its historical average?